| Literature DB >> 33371083 |
Gopal Nambi1, Walid Kamal Abdelbasset1,2, Saud F Alsubaie1, Samah A Moawd1,3, Anju Verma1, Ayman K Saleh4,5, Nahla N Ataalla6.
Abstract
BACKGROUND: Isokinetic training (IKT) and core stabilization training (CST) are commonly used for balance training in musculoskeletal conditions. The knowledge about the effective implementation of these training protocols on radiological and biochemical effects in university football players with chronic low back pain (LBP) is lacking.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33371083 PMCID: PMC7748199 DOI: 10.1097/MD.0000000000023555
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow chart showing the study details.
Demographic characters of IKT, CST, and control groups.
| Sr.No | Variable | IKT | CST | Control | |
| 1 | Age (yr) | 22.1 ± 1.8 | 22.3 ± 1.7 | 21.9 ± 1.8 | .774∗ |
| 2 | Height (m) | 1.67 ± 0.17 | 1.72 ± 0.18 | 1.71 ± 0.17 | .630∗ |
| 3 | Weight (kg) | 67.6 ± 2.9 | 68.6 ± 2.8 | 69.6 ± 3.1 | .107∗ |
| 4 | BMI (kg/m2) | 24.2 ± 1.4 | 24.6 ± 1.3 | 23.9 ± 1.4 | .275∗ |
| 5 | VO2peak (mL/kg/min) | 37.6 ± 3.9 | 38.2 ± 4.1 | 37.9 ± 4.2 | .897∗ |
| 6 | HR (beats/min) | 172 ± 7.2 | 173 ± 6.9 | 173 ± 7.3 | .877∗ |
| 7 | Years of playing (yr) | 4.5 ± 1.7 | 4.8 ± 1.5 | 4.4 ± 1.5 | .704∗ |
| 8 | Duration of Injury (m) | 4.2 ± 0.8 | 4.6 ± 0.7 | 4.7 ± 0.6 | .068∗ |
Pre and post mean difference and confidence interval (upper limit and lower limit) scores of IKT, CST, and control groups.
| Mean difference CI95% (Upper limit – Lower limit) | ||||||||
| Variable / Time | Baseline | After 4 wk | ||||||
| Pain intensity (VAS – cm) | IKT | IKT vs Control | 7.4 ± 0.5 | −0.1 (−0.41 to 0.21) | .720∗ | 1.2 ± 0.3 | 4.3 (3.98 to 4.61) | .838∗ |
| CST | CST vs Control | 7.2 ± 0.4 | 0.10 (−0.21 to 0.41) | .720∗ | 3.8 ± 0.5 | 4.3 (3.98 to 4.61) | .001 | |
| Control | IKT vs CST | 7.3 ± 0.3 | −0.2 (−0.51 to 0.11) | .276∗ | 5.5 ± 0.4 | 2.6 (2.28 to 2.91) | .001 | |
| .308∗ | .001 | |||||||
| Psoas Major CSA (cm2) – R | IKT | IKT vs Control | 8.8 ± 0.4 | −0.3 (−0.63 to 0.03) | .084∗ | 10.9 ± 0.4 | −2.1 (−2.39 to −1.80) | .001 |
| CST | CST vs Control | 8.7 ± 0.5 | −0.2 (−0.53 to 0.13) | .322∗ | 9.2 ± 0.5 | −0.4 (−0.69 to −0.10) | .005 | |
| Control | IKT vs CST | 8.5 ± 0.4 | −0.1 (−0.43 to 0.23) | .749∗ | 8.8 ± 0.2 | −1.7 (−1.99 to −1.40) | .001 | |
| .094∗ | .001 | |||||||
| Psoas Major CSA (cm2) – L | IKT | IKT vs Control | 8.2 ± 0.4 | −0.3 (−0.68 to 0.08) | .807∗ | 10.8 ± 0.4 | −2.4 (−2.68 to −2.11) | .001 |
| CST | CST vs Control | 8.1 ± 0.6 | −0.2 (−0.58 to 0.18) | .430∗ | 8.9 ± 0.3 | −0.5 (−0.78 to −0.21) | .001 | |
| Control | IKT vs CST | 7.9 ± 0.5 | −0.1 (−0.48 to 0.28) | .807∗ | 8.4 ± 0.4 | −1.9 (−2.18 to −1.61) | .001 | |
| .171∗ | .001 | |||||||
| Quadratus. Lumborum CSA (cm2) – R | IKT | IKT vs Control | 4.5 ± 0.7 | 0.30 (−0.20 to 0.80) | .337∗ | 6.9 ± 0.3 | −1.8 (−2.05 to −1.54) | .001 |
| CST | CST vs Control | 4.3 ± 0.6 | 0.50 (−0.00 to 1.00) | .055∗ | 5.5 ± 0.4 | −0.4 (−0.65 to −0.14) | .001 | |
| Control | IKT vs CST | 4.8 ± 0.7 | −0.2 (−0.70 to 0.30) | .613∗ | 5.1 ± 0.3 | −1.4 (−1.65 to −1.14) | .001 | |
| .067∗ | .001 | |||||||
| Quadratus. Lumborum CSA (cm2) – L | IKT | IKT vs Control | 4.5 ± 0.3 | 0.0 (−0.23 to 0.23) | 1.000∗ | 7.1 ± 0.3 | −1.7 (−1.95 to −1.44) | .001 |
| CST | CST vs Control | 4.3 ± 0.4 | 0.20 (−0.03 to 0.43) | .113∗ | 5.6 ± 0.4 | −0.2 (−0.45 to 0.05) | .154∗ | |
| Control | IKT vs CST | 4.5 ± 0.2 | −0.2 (−0.43 to 0.03) | .113∗ | 5.4 ± 0.3 | −1.5 (−1.75 to −1.24) | .001 | |
| .071∗ | .001 | |||||||
| Multifidus CSA (cm2) – R | IKT | IKT vs Control | 5.4 ± 0.5 | 0.10 (−0.23 to 0.43) | .749∗ | 7.7 ± 0.4 | −2.0 (−2.31 to −1.68) | .001 |
| CST | CST vs Control | 5.2 ± 0.4 | 0.30 (−0.03 to 0.63) | .084∗ | 5.9 ± 0.5 | −0.2 (−0.51 to 0.11) | .276∗ | |
| Control | IKT vs CST | 5.5 ± 0.4 | −0.20 (−0.53 to 0.13) | .322∗ | 5.7 ± 0.3 | −1.8 (−2.11 to −1.48) | .001 | |
| .094∗ | .001 | |||||||
| Multifidus CSA (cm2) – L | IKT | IKT vs Control | 5.2 ± 0.7 | 0.50 (−0.00 to 1.00) | .055∗ | 7.8 ± 0.5 | −1.9 (−2.21 to −1.58) | .001 |
| CST | CST vs Control | 5.4 ± 0.7 | 0.30 (−0.20 to 0.80) | .337∗ | 6.2 ± 0.3 | −0.30 (−0.61 to 0.01) | .060∗ | |
| Control | IKT vs CST | 5.7 ± 0.6 | 0.20 (−0.30 to 0.70) | .613∗ | 5.9 ± 0.4 | −1.6 (−1.91 to −1.28) | .001 | |
| .067∗ | .001 | |||||||
| Erector Spinae CSA (cm2) – R | IKT | IKT vs Control | 15.9 ± 0.4 | 0.3 (−0.06 to 0.66) | .123∗ | 19.1 ± 0.3 | −2.2 (−2.48 to −1.91) | .001 |
| CST | CST vs Control | 16.1 ± 0.6 | 0.1 (−0.26 to 0.46) | .785∗ | 17.4 ± 0.4 | −0.5 (−0.78 to −0.21) | .001 | |
| Control | IKT vs CST | 16.2 ± 0.4 | 0.2 (−0.16 to 0.56) | .385∗ | 16.9 ± 0.4 | −1.7 (−1.98 to −1.41) | .001 | |
| .137∗ | .001 | |||||||
| Erector Spinae CSA (cm2) – L | IKT | IKT vs Control | 16.5 ± 0.5 | 0.2 (−0.15 to 0.55) | .374∗ | 18.8 ± 0.5 | −1.7 (−2.01 to −1.38) | .001 |
| CST | CST vs Control | 16.8 ± 0.4 | −0.1 (−0.45 to 0.25) | .779∗ | 17.3 ± 0.4 | −0.2 (−0.51 to 0.11) | .276∗ | |
| Control | IKT vs CST | 16.7 ± 0.5 | 0.3 (−0.05 to 0.65) | .116∗ | 17.1 ± 0.3 | −1.5 (−1.81 to −1.18) | .001 | |
| .129∗ | .001 | |||||||
| Multifidus Thickness (mm) R | IKT | IKT vs Control | 33.5 ± 3.2 | −1.3 (−3.86 to 1.26) | .446∗ | 35.1 ± 1.3 | −2.2 (−3.19 to −1.20) | .001 |
| CST | CST vs Control | 32.8 ± 3.4 | −0.6 (−3.16 to 1.96) | .840∗ | 33.2 ± 1.4 | 0.1 (−0.89 to 1.09) | .968∗ | |
| Control | IKT vs CST | 32.2 ± 3.5 | −0.7 (−3.26 to 1.86) | .789∗ | 32.9 ± 1.2 | −2.3 (−3.29 to −1.30) | .001 | |
| .478∗ | .001 | |||||||
| Multifidus Thickness (mm) L | IKT | IKT vs Control | 31.4 ± 2.8 | −0.3 (−2.61 to 2.01) | .947∗ | 34.8 ± 1.1 | −0.9 (−1.7 to −0.03) | .039 |
| CST | CST vs Control | 31.3 ± 3.1 | −0.2 (−2.51 to 2.11) | .976∗ | 34.5 ± 1.1 | −0.6 (−1.46 to 0.26) | .224∗ | |
| Control | IKT vs CST | 31.1 ± 3.2 | −0.1 (−2.41 to 2.21) | .994∗ | 33.9 ± 1.2 | −0.3 (−1.16 to 0.56) | .682∗ | |
| .950∗ | .045 | |||||||
Figure 2Post MRI analysis of IKT, CST and Control groups.
Figure 3Pre and Post US analysis of IKT, CST and Control groups.
Pre and post mean difference and confidence interval (upper limit and lower limit) of pro inflammatory biomarker analysis scores of IKT, CST, and control groups.
| Mean difference CI95% (Upper limit – Lower limit) | ||||||||
| Variable / Time | Baseline | After 4 wk | ||||||
| CRP Mg/l | IKT | IKT vs Control | 7.4 ± 0.5 | −0.06 (−0.39 to 0.27) | .901∗ | 1.2 ± 0.3 | 0.8 (0.66 to 0.93) | .001 |
| CST | CST vs Control | 7.2 ± 0.4 | −0.04 (−0.37 to 0.29) | .954∗ | 3.8 ± 0.5 | 0.4 (0.26 to 0.53) | .001 | |
| Control | IKT vs CST | 7.3 ± 0.3 | −0.02 (−0.35 to 0.31) | .988∗ | 5.5 ± 0.4 | 0.4 (0.26 to 0.53) | .001 | |
| .906∗ | .001 | |||||||
| TNF-α Pg/ml | IKT | IKT vs Control | 8.8 ± 0.4 | 0.0 (−0.35 to 0.35) | 1.000∗ | 10.9 ± 0.4 | 6.7 (6.36 to 7.03) | .874∗ |
| CST | CST vs Control | 8.7 ± 0.5 | 0.30 (−0.05 to 0.65) | .116∗ | 9.2 ± 0.5 | 3.2 (2.86 to 3.53) | .014 | |
| Control | IKT vs CST | 8.5 ± 0.4 | −0.30 (−0.65 to 0.05) | .116∗ | 8.8 ± 0.2 | 3.5 (3.16 to 3.83) | .132∗ | |
| .073∗ | .001 | |||||||
| IL-2 | IKT | IKT vs Control | 8.2 ± 0.4 | −0.2 (−0.66 to 0.26) | .522∗ | 10.8 ± 0.4 | −3.1 (−3.43 to −2.76) | .006 |
| CST | CST vs Control | 8.1 ± 0.6 | −0.30 (−0.76 to 0.16) | .268∗ | 8.9 ± 0.3 | −1.2 (−1.53 to −0.86) | .001 | |
| Control | IKT vs CST | 7.9 ± 0.5 | 0.10 (−0.36 to 0.56) | .860∗ | 8.4 ± 0.4 | −1.9 (−2.23 to −1.56) | .001 | |
| .287∗ | .001 | |||||||
| IL-4 | IKT | IKT vs Control | 4.5 ± 0.7 | −0.2 (−0.73 to 0.33) | .644∗ | 6.9 ± 0.3 | −22.1 (−23.5 to −20.6) | .872∗ |
| CST | CST vs Control | 4.3 ± 0.6 | −0.5 (−1.03 to 0.03) | .072∗ | 5.5 ± 0.4 | −10.4 (−11.8 to −8.9) | .001 | |
| Control | IKT vs CST | 4.8 ± 0.7 | 0.3 (−0.23 to 0.83) | .375∗ | 5.1 ± 0.3 | −11.7 (−13.1 to −10.2) | .001 | |
| .086∗ | .001 | |||||||
| IL-6 | IKT | IKT vs Control | 4.5 ± 0.3 | −0.2 (−0.51 to 0.11) | .276∗ | 7.1 ± 0.3 | 3.2 (2.96 to 3.43) | .814∗ |
| CST | CST vs Control | 4.3 ± 0.4 | 0.1 (−0.21 to 0.41) | .720∗ | 5.6 ± 0.4 | 0.7 (0.46 to 0.93) | .001 | |
| Control | IKT vs CST | 4.5 ± 0.2 | −0.30 (−0.61 to 0.01) | .060∗ | 5.4 ± 0.3 | 2.5 (2.26 to 2.73) | .132∗ | |
| .069∗ | .001 | |||||||
Figure 4Pre and Post analysis of IL-2, IL-4 and IL-6 of IKT, CST, and Control groups.